Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
INOVIO has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG, to support large-scale manufacturing of INOVIO's investigational DNA vaccine INO-4800.
read more
Catalent’s Biologics business unit will accelerate availability of manufacturing capacity and prepare for large-scale commercial manufacturing of Johnson & Johnson’s lead vaccine candidate for COVID-19.
read more
Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services announced a development collaboration agreement to evaluate AJICAP.
read more
CrO Biosciences announced Laura A. Jones as President. Jones will focus on leading global regulatory strategic development, oversight of regulatory operations, clinical operations and R&D systems implementation strategies.
read more
Avacta has entered into a collaboration with Adeptrix to develop a high throughput COVID-19 antigen test using Adeptrix’s proprietary BAMS™ platform.
read more
Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture of Moderna’s mRNA vaccine against the novel coronavirus.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing services agreement with CytoDyn for the supply of the investigational new drug, leronlimab.
read more
Catalent announced the appointment of Manja Boerman, Ph.D., to the role of President, Cell & Gene Therapy, effective June 1, 2020.
read more
Aravive and WuXi Biologics announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.
read more
PrecisionLife is extending its relationships with some of the COVID-19 collaborative research projects and is offering free use of its analytics platform.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Clinical Ink has announced a wide-ranging Study Assurance Program to minimize financial impact of the disruption from COVID-19 on new and existing clinical trials.
read more
ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.
read more
Key Biologics and Astarte Biologics announced the launch of an IRB-approved initiative to support the research, therapeutic, and vaccine communities with access to blood products collected from COVID-19 convalescent donors.
read more